insights_auto
Why is C1TV34 up 2.44%?
Dive Deeperchevron_right
C1TV34:BVMF
Corteva Inc Bdr
R$17.64
arrow_upward
+2.44%(+0.42) 1D
Oct 7, 11:51:31 AM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for C1TV34...
Open
R$17.92
High
R$17.92
Low
R$17.44
Mkt. cap
9.50B
Avg. vol.
579.00
Volume
520.00
52-wk high
R$115.51
52-wk low
R$16.10
Shares outstanding
667.30M
No. of employees
22K
Open
R$17.92
High
R$17.92
Low
R$17.44
Mkt. cap
9.50B
Avg. vol.
579.00
Volume
520.00
52-wk high
R$115.51
52-wk low
R$16.10
Shares outstanding
667.30M
No. of employees
22K
News stories
From web sources and news partners
Barron's
·
38 minutes ago
Why Less Is More for Corteva Stock After Vylor Spinoff
Investing.com
·
3 hours ago
RBC Capital cuts Corteva stock price target to $17 on spin-off
Yahoo Finance
·
20 hours ago
Why Corteva Stock Is Rocketing Higher Today
Kalkine Media
·
22 hours ago
Judd M. O'Connor Receives 92,768 Shares in Vylor Inc. Following Corteva Spin-Off
Profile
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International. Wikipedia
About Corteva Inc Bdr
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.62B | 3.91B | 4.90B | 6.38B |
Cost of goods sold | 1.64B | 2.25B | 2.37B | 2.72B |
Cost of revenue | 1.64B | 2.25B | 2.37B | 2.72B |
Research and development expenses | 351.00M | 413.00M | 341.00M | 388.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 731.00M | 865.00M | 870.00M | 1.16B |
Operating expense | 1.24B | 1.44B | 1.37B | 1.74B |
Total operating expenses | 2.89B | 3.69B | 3.74B | 4.46B |
Operating income | -270.00M | 219.00M | 1.16B | 1.92B |
Other non operating income | - | -34.00M | -19.00M | -25.00M |
EBT including unusual items | -370.00M | -530.00M | 858.00M | 1.62B |
EBT excluding unusual items | -333.00M | 103.00M | 1.09B | 1.79B |
Income tax expense | -62.00M | 7.00M | 133.00M | 408.00M |
Effective tax rate | 16.76% | -1.32% | 15.50% | 25.11% |
Other operating expenses | - | - | - | - |
Net income | -320.00M | -552.00M | 720.00M | 1.16B |
Net profit margin | -12.22% | -14.12% | 14.68% | 18.20% |
Earnings per share | -0.23 | 0.22 | 1.50 | 2.30 |
Interest and investment income | 29.00M | 44.00M | 34.00M | 27.00M |
Interest expense | -46.00M | -46.00M | -36.00M | -47.00M |
Net interest expenses | -17.00M | -2.00M | -2.00M | -20.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 30.00M | 525.00M | 1.46B | 2.26B |
Gain or loss from assets sale | - | -24.00M | 3.00M | 3.00M |